Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

FSD Pharma says biosciences division being hailed as 'the best untold biotech story'

What are you searching for? viewFSD Pharma Inc's () (NASDAQ:HUGE) Dr Ed Brennan sat down with Proactive’s Christine Corrado at the Biotech Showcase 20...

FSD Pharma takes major step forward listing on Nasdaq under the symbol “HUGE”

What are you searching for? viewFSD Pharma (NASDAQ: HUGE-CSE: HUGE) Executive Co-Chairman and CEO Dr Raza Bokhari, joined Steve Darling from Proactive...

FSD Pharma starts trading on Nasdaq

The move will expand awareness of its lead asset, micro-PEA, a micronized formulation of palmitolylethonalamide CEO Raza Bokhari said a Nasdaq listing...

Buds & Duds: Cannabis stocks start the year quietly, FSD gains on new executive appointments

What are you searching for? The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 0.8% at 118.4 points. ...

Buds & Duds: Cannabis stocks start the year quietly, FSD gains on new executive appointments

Also moving were Westleaf, TransCanna Holdings and Harvest Health & Recreation Cannabis stocks started the first trading day of the year in the re...

FSD Pharma bolsters management team with three key hires

Donal Carroll is the CFO, Dr Sandra Lottes head of clinical research of the BioSciences division, and Shahzad Shah COO FSD Pharma recently scored a ma...

Buds & Duds: Cannabis sector remains flattish; FSD makes gains on Nasdaq uplisting news

What are you searching for? The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 0.3% higher at 116 poin...

Buds & Duds: Cannabis sector remains flattish; FSD makes gains on Nasdaq uplisting news

The major marijuana indices all hovered around flat Cannabis stocks were relatively quiet Monday, as the sector remained largely unchanged.  The North...

FSD Pharma gets nod to uplist on Nasdaq

What are you searching for? viewFSD Pharma The move will enhance the Canadian company’s visibility and increase the liquidity of the stock PP 101 is t...

FSD Pharma 'hunkering down' on grow facility and 'doubling down' on biosciences effort

What are you searching for? viewFSD Pharma Inc () (OTCMKTS:FSDDF) CEO Raza Bokhari reveals 3Q highlights for the medically-focused cannabis company. B...

FSD Pharma to initiate Phase 1 safety trials for its lead drug candidate PP 101 micro-PEA in 1Q 2020

With over $70 million in cash and assets, it has enough financial muscle to transform into a specialty pharmaceutical R&D company PP 101 is the fi...

FSD Pharma has now raised C$4.59M in private placing and extends it to third tranche

Net proceeds will be used for the expansion of the group's biosciences division, said the firm FSD had expected to close the placing by October 31 but...

FSD Pharma strengthens board with new appointment

What are you searching for? viewFSD Pharma Inc () (OTCMKTS:FSDDF) CEO Raza Bokhari tells Proactive the company has appointed ex-US Congressman Stephen...

FSD Pharma appoints ex-US Congressman Stephen Buyer to board; announces share consolidation

Its Class A multiple voting shares and Class B subordinate voting shares will be consolidated on a 1-to-201 basis The Cobourg, Ontario-based company i...

Buds & Duds: Cannabis stocks remain mostly flat heading into the weekend; Canopy Growth falls after Constellation Brands writedown

What are you searching for? The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was in the green to start t...

Buds & Duds: Cannabis stocks remain mostly flat heading into the weekend; Canopy Growth falls after Constellation Brands writedown

Litelink Technologies moved higher on Friday after signing a new agreement to track cannabis plantlets Also on the move was FSD Pharma, Kalytera Thera...

FSD Pharma extends private placement to second tranche to accommodate potential additional interest

It said the first tranche raised gross proceeds of C$4,583,085 from investors, issuing an aggregate of 45,830,850 shares at a price of C$0.10 each The...

FSD Pharma inks Letter of Intent for joint cannabis extraction venture with World-Class Extractions

The five-year deal will see the companies extract CBD and other elements at FSD's facility using World-Class' machinery At the facility, FV Pharma wil...

Zachs Small-Cap Research initiates coverage on FSD Pharma with a comparable analysis valuation price target of $0.23

Zachs thinks FSD Pharma is well positioned to benefit from the legalization of cannabis in Canada, Germany, the rest of the Eurozone and the US It not...

FSD Pharma expects to report meaningful medical cannabis sales revenue in 3Q

What are you searching for? viewFSD Pharma Inc () (OTCMKTS:FSDDF) CEO Dr. Raza Bokhari tells Proactive the cannabis company expects to report meaningf...


MjInvest.com